Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist (Q40048436)
Jump to navigation
Jump to search
scientific article published on December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist |
scientific article published on December 2007 |
Statements
1 reference
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist (English)
1 reference
1 reference
Bridget Charbonneau
1 reference
Timothy L Ratliff
1 reference
Andrew D Weinberg
1 reference
1 December 2007
1 reference
1 reference
Identifiers
1 reference